The residual effectiveness of pyrethroid-treated foliage as a barrier against female Aedes albopictus and Culex quinquefasciatus was evaluated in large screened cage field tests. Individual potted southern wax myrtle, Myrica certifica, plants were treated with either Aqua Reslin® 20 20 emulsifiable concentrate (EC) (20% active ingredient [AI] permethrin 20% [AI] piperonyl butoxide), Permanone® EC (10% [AI] permethrin), or Suspend® suspension concentrate (SC) (4.75% [AI] deltamethrin) at maximum label rates. Generally, Aqua Reslin provided ≈83% overall reduction of mosquitoes during the week of treatment. After that time, mosquito reduction decreased to <50% and continued at this level for the remainder of the 12-wk study. Mosquito knockdown/mortality from excised Aqua Reslin-treated leaves revealed that this formulation quickly lost effectiveness after the initial week of treatment. Plants treated with Permanone provided ≈70% and 64% overall reduction during the week of, and first week after treatment, respectively. Knockdown/mortality from excised leaf bioassays of leaves treated with this formulation fell below 50% 2 wk after treatment where it remained for the rest of the study. Suspend generally provided 70 to ≈80% overall mosquito reduction during the first 4 weeks after treatment and decreased to <50% thereafter. Residues on treated leaves provided >95% overall knockdown/mortality throughout the study and was not correlated with weekly reduction in the field cages. We believe this disparity was in part attributed to new plant growth. Newly formed leaves probably provided nontoxic surfaces for mosquito harborage.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 22 • No. 4